BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22858223)

  • 1. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of andrographolide derivatives as potent anti-HIV agents.
    Tang C; Liu Y; Wang B; Gu G; Yang L; Zheng Y; Qian H; Huang W
    Arch Pharm (Weinheim); 2012 Aug; 345(8):647-56. PubMed ID: 22592973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preliminary anti-HIV activities of andrographolide derivatives.
    Wang B; Ge L; Huang W; Zhang H; Qian H; Li J; Zheng Y
    Med Chem; 2010 Jul; 6(4):252-8. PubMed ID: 20879977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
    Teixeira C; Serradji N; Maurel F; Barbault F
    Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
    Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of HIV-1 entry inhibitors based on broadly neutralizing antibody 447-52D and gp120 V3loop interactions.
    Senapathi J; Bommakanti A; Vangara S; Kondapi AK
    Bioorg Chem; 2021 Nov; 116():105313. PubMed ID: 34517280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.
    Wang T; Kadow JF; Zhang Z; Yin Z; Gao Q; Wu D; Parker DD; Yang Z; Zadjura L; Robinson BA; Gong YF; Spicer TP; Blair WS; Shi PY; Yamanaka G; Lin PF; Meanwell NA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5140-5. PubMed ID: 19664921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
    Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
    J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues.
    Bewley CA; Ray S; Cohen F; Collins SK; Overman LE
    J Nat Prod; 2004 Aug; 67(8):1319-24. PubMed ID: 15332849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.
    Nanduri S; Nyavanandi VK; Thunuguntla SS; Kasu S; Pallerla MK; Ram PS; Rajagopal S; Kumar RA; Ramanujam R; Babu JM; Vyas K; Devi AS; Reddy GO; Akella V
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4711-7. PubMed ID: 15324893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
    Rivero-Buceta E; Doyagüez EG; Colomer I; Quesada E; Mathys L; Noppen S; Liekens S; Camarasa MJ; Pérez-Pérez MJ; Balzarini J; San-Félix A
    Eur J Med Chem; 2015 Dec; 106():34-43. PubMed ID: 26513643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
    Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
    AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
    Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
    Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.